192 results on '"Salama J.K."'
Search Results
2. Clinical Outcomes Following an Initial Stereotactic Radiosurgery Course for Brain Metastases from Melanoma
3. Evaluating the Reliability of Chat-GPT Model Responses for Radiation Oncology Patient Inquiries
4. Pretreatment Clinical Parameters Associated with Intracranial Progression Burden Following an Initial Stereotactic Radiosurgery Course in a Multi-Institutional Brain Metastases Cohort
5. ChatGPT is an Unreliable Tool for Reviewing Radiation Oncology Literature
6. Survival and Recurrence Rates Following SBRT or Surgery in Medically Operable Stage I NSCLC.
7. Early Imaging Characteristics Associated with Development of Future Brain Metastases in Patients Undergoing Stereotactic Radiosurgery
8. A Deep Learning-Based Computer Aided Detection (CAD) System for Difficult-to-Detect Brain Metastases (BM)
9. Enhancing Radiation Therapy Plan Quality in a Multi-Site Randomized Clinical Trial with a Benchmark Credentialing Exercise: The VA STARPORT Experience
10. Association between Results from the 17-Gene Genomic Prostate Score Assay and Long-Term Outcomes after External Beam Radiation Therapy in Intermediate- or High-Risk Prostate Cancer Patients, Independent of Race
11. P2.07B.04 Comparative Effectiveness of Sub-Lobar Resection vs Lobectomy for Medically Operable Stage I NSCLC: A VACCR Analysis
12. Veterans Affairs seamless phase II/III randomized trial of STAndard systemic theRapy with or without PET-directed local therapy for Oligometastatic pRosTate cancer (VA STARPORT)
13. Association of MRI Capsular Involvement and Extraprostatic Extension on Metastasis Free and Overall Survival in Localized Prostate Cancer Treated with Radiation
14. Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck
15. A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers
16. The Oncotype DX Genomic Prostate Score® assay is associated with time to distant metastasis and prostate cancer death after external beam radiation therapy in localized prostate cancer: A retrospective study
17. Dosimetric Predictors of Toxicity in Patients With Early-Stage Prostate Cancer Treated With Moderately Hypofractionated IMRT or PBT: A Multi-Institutional Analysis
18. The Role of Hypofractionated Radiation Therapy in the Management of Unresectable Hepatocellular Carcinoma (HCC)
19. Oligometastases Treated With an Elective Simultaneous Integrated Boost Have Reduced Marginal Recurrence Rates
20. Toxicity and Dosimetric Parameters of Ablative Radiation Therapy in the Management of Patients with Child-Pugh B/C Liver Function and Unresectable Hepatocellular Carcinoma (HCC)
21. Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels
22. Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma
23. Does Efficacy and Toxicity Differ According to Prostate Volume in Men Treated with Moderately Hypofractionated Radiation Therapy?
24. Effective pain control with very low dose palliative radiotherapy for multiple myeloma patients with painful osseous lesions
25. Long-Term Experience in an Equal Access Health Care System Using Moderately Hypofractionated Radiotherapy for High Risk Prostate Cancer in a Predominately African American Population With Unfavorable Disease
26. Radiation Therapy and Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment
27. A Multi-institutional, Propensity Score-Weighted Comparison of Moderately Hypofractionated Photon and Proton Therapy for 1850 Patients with Low or Intermediate Risk Prostate Cancer
28. A0963 - The Oncotype DX Genomic Prostate Score® assay is associated with time to distant metastasis and prostate cancer death after external beam radiation therapy in localized prostate cancer: A retrospective study
29. Radiation Therapy Prior to Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment
30. Phase I Trial of Stereotactic Body Radiation Therapy (SBRT) to Multiple Metastatic Sites: A NRG Oncology Study
31. Patient Factors Predicting Intracranial Progression: Optimizing MRI Surveillance Interval Following Brain Metastases SRS
32. Evaluation of Post-Stereotactic Body Radiation Therapy Response Assessment for Hepatocellular Carcinoma: An Appraisal of RECIST, m-RECIST and WHO Criteria
33. Modeling and Prediction of SIB Prostate IMRT Plans
34. The Impact of Biologically Equivalent Dose on Tumor Control in Unresectable Hepatocellular Carcinoma
35. Non-operative Management for Locally Advanced Rectal Cancer in the Veterans Health Administration
36. Once Versus Twice Daily Fractionation for Limited Stage SCLC
37. Toxicity and Biochemical Outcomes of Hypofractionated Intensity Modulated Post-Operative Radiation Therapy for Prostate Cancer
38. Predicting for Long-Term Survival in Oligometastatic Patients Treated With Ablative Radiation Therapy: A Multi-institutional Pooled Analysis
39. Toxicity and Survival for Metastatic Melanoma Patients Treated With Anti-PD1 Therapy and Radiation Treatment
40. Triphasic Bolus Tracking Computed Tomography Simulation for Stereotactic Body Radiation Therapy of Locoregionally Advanced Pancreatic Cancer
41. Hippocampal Dose From Stereotactic Radiosurgery for 4 to 10 Brain Metastases: Risk Factors and Feasibility of Dose Reduction Via Reoptimization
42. The Use of Reirradiation in Locally Recurrent, Nonmetastatic Rectal Cancer
43. Survival With Stereotactic Body Radiation Therapy (SBRT) and Conventional Radiation Therapy (CRT) in Stage I Non-Small Cell Lung Cancer Patients in the Veterans Affairs System
44. Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors
45. Radiation Oncologists’ Practice Patterns and Attitudes Regarding Neoadjuvant Short-Course Radiation Therapy for Rectal Cancer in the United States
46. Radiosurgery for Brain Metastases in Melanoma Patients Receiving Ipilimumab
47. Benchmark Credentialing Results for the First Multiple Metastases SBRT Protocol: NRG BR001
48. Long-term Survivors of an SBRT Dose-Escalation Study for Oligometastases: Clinical and Molecular Markers
49. When is a Biopsy-Proven Diagnosis Necessary Before Stereotactic Ablative Radiation Therapy for Lung Cancer? A Decision Analysis
50. A Multi-institution Pooled Analysis of Oligometastatic Patients Treated With SBRT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.